ExStax, a cannabis technology company based in Mesa, Arizona, has announced the launch of the first stackable dual cartridge vaporizer. Made with medical grade components, the patented-technology is universally compatible with existing .510 cartridges on the market, and is compatible with a large majority of .510 batteries, allowing consumers to blend cannabis, tobacco, and CBD/hemp vapor products.
The innovative cartridge design is available in .3, .5, .7, and 1.0 ml , or “stacks,” and is not exclusive to cannabis terpenes. The custom aperture holes allow for different liquids, revolutionizing vape retail. For the first time ever, consumers can mix and match, combine, or, stack their cartridges, creating a completely unique personalized vape experience. Mixing two strains and creating a custom hybrid is just the tip of the iceberg for this groundbreaking company as there are years worth of formulations and combinations ready to be prepped, mixed and packaged.
“This new world of vapor technology promotes cross-industry collaboration between cannabis and retail brands, while engaging a diverse consumer base. Our technology has the ability to combine any two vapeable substances at your fingertips,” said Rick Avila, one of the patent developers and co-CEO at ExStax™.
Avila and his partners spent years engineering the Stak’d™ cartridge design before co-founding the company ExStax™ with Chris Botti in 2022.
Headquartered in Mesa, Arizona, ExStax™ includes a removable mouthpiece with every cartridge purchase. Consumers have the option to enjoy traditionally by screwing on the mouthpiece and battery, or with the patented system, mix and match, by removing the mouthpiece and stacking an additional cartridge on top.
According to a recent Headset.io report, vape pens are the second most popular marijuana category behind flower in the U.S. and the vape market is only projected to grow as more consumers seek out personalized, higher-potency products.
“Our new revolutionary design is fueled by innovation and empowered by collaboration,” said Chris Botti, co-CEO at ExStax™.
For more information, visit exstax.com.
Photo: ExStax, prnewswire